When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Chlamydia pneumoniae infection

Evidence last reviewed: 20 Apr 2026
Topic last updated: 19 May 2026

Summary

Definition

History and exam

Other diagnostic factors

  • overcrowding (risk factor)
  • illness in other family members
  • cough
  • fever
  • headache
  • crackles on chest auscultation
  • wheezes on chest auscultation
  • tachypnea
  • pleuritic chest pain
  • dullness to percussion/reduced air entry/decreased tactile fremitus
Full details

Risk factors

  • overcrowding
Full details

Diagnostic tests

1st tests to order

  • chest x-ray
  • WBC count with differential
  • nucleic acid amplification tests for Chlamydia pneumoniae
Full details

Treatment algorithm

ACUTE

adults

children

Contributors

Authors

Margaret R. Hammerschlag, MD

Professor of Pediatrics and Medicine

Director

Division of Pediatric Infectious Diseases

SUNY Downstate Medical Center

Brooklyn, NY

Disclosures

MRH is an author of a number of references cited in this topic.

Peer reviewers

Florian Tagini, MD, PhD

Infectious disease physician

Lausanne University Hospital

Lausanne

Switzerland

Disclosures

FT declares that he has no competing interests.

David L Hahn, MD, MS

Clinical Advisory Board

Intracell Research Group

Wake Forest, NC

Disclosures

DLH declares that he has no competing interests.

Yuji Oba, MD, FCCP

Associate Professor of Clinical Medicine

Division of Pulmonary/Critical Care Medicine

School of Medicine

University of Missouri-Columbia

Columbia, MO

Disclosures

YO declares that he has no competing interests.

Sebastian Johnston, MB, BS, PhD, FRCP

Professor of Respiratory Medicine

Honorary Consultant Physician in Allergy and Respiratory Medicine

Department of Respiratory Medicine

Imperial College School of Medicine

London

UK

Disclosures

SJ has received fees for speaking, and research and consultant fees from Sanofi Pasteur, Aventis, GlaxoSmithKline, AstroZeneca, Merck, Pfizer, Centocor, and Synergen.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis. 2007 Feb 15;44(4):568-76. Abstract

Hammerschlag MR, Kohlhoff SA, Dean D. Chlamydia pneumoniae. In: Blaser MJ, Cohen JI, Holland SM, eds. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 10th ed. Philadelphia, PA: Elsevier; 2025:188, 2296-304.

Rockey DD, Lenart J, Stephens RS. Genome sequencing and our understanding of Chlamydiae. Infect Immun. 2000 Oct;68(10):5473-9.Full text  Abstract

Tagini F, Puolakkainen M, Greub G, et al. From coughs to complications: the story of Chlamydia pneumoniae. J Med Microbiol. 2025 Apr;74(4):002006.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Chlamydia pneumoniae infection images
  • Differentials

    • Coronavirus disease 2019 (COVID-19)
    • Mycoplasma pneumoniae pneumonia
    • Pneumonia, bacterial
    More Differentials
  • Guidelines

    • Diagnosis and treatment of adults with community-acquired pneumonia
    More Guidelines
  • Patient information

    Pneumonia

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer